Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Recurrence 1Lung Neoplasms 1Leiomyoma 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

telapristone acetate 18ulipristal acetate 17Uterine Myomectomy 13vilaprisan 12Leuprolide 11relugolix 9estradiol, norethindrone drug combination 9asoprisnil 9elagolix 7Uterine Artery Embolization 7Mifepristone 7Estradiol 7Bupivacaine 7ulipristal 6Tranexamic Acid 6Saline Solution 5Norethindrone Acetate 5linzagolix 4epigallocatechin gallate 4Sodium Chloride 4Letrozole 4Hysterectomy 4Vitamin B 6 3Sugars 3Misoprostol 3Lidocaine 3Gonadotropin-Releasing Hormone 3Embolization, Therapeutic 3cetrorelix 2Vitamin D 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Leiomyoma × DMAC2L protein, human × Clear all
NCT06640738 2024-10-15

Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid Ablation

Kaohsiung Medical University

Phase 4 Not yet recruiting
60 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡